Research

Since 1989 when Canadian researchers discovered the gene responsible for CF, global research to find a cure for the disease has brought us closer and closer to a solution.  While Canada is consistently at the forefront of CF research as a result of financial support through the Canadian Cystic Fibrosis Foundation, the search for a cure for CF is a world-wide enterprise.
 
NOTICE: On this page we will be highlighting research news from various sources all over the world. But in doing so we wish to explicitly state that this is for general information purposes only, and while some of this news around proposed new treatment of CF seems promising at times, they are but a small part of thousands of research projects world-wide searching for a cure for CF.  None of the proposed treatments you might be reading about here is either endorsed by the CCFF or by the medical community concerned with CF.  As always, it is the CF clinician and other medical professionals entrusted with the care of CF patients who should be the deciding authority in determining what treatment is best for a person with CF.

Filter     Order     Display # 
Item Title
(US) PARI Pharma's Altera Cleared to Deliver Inhaled Antibiotic Cayston
(US) FDA Approves New Inhaled Antibiotic For CF
(IT) Carrier Screening Associated with Decrease in Incidence of CF
(AU) CF Carrier Testing Should Be Available Prior to Pregnancy
(EU) Lung Tissue Generated From Human Embryonic Stem Cells
(US) EU Grants Conditional Marketing Authorization For Cayston(R)
(US) KB001 Antibody Shows Encouraging Results In Fighting P. a.
(US-NL) Gene Identified For Short-circuiting Excess Mucus In Lungs
(US) PTC Therapeutics Initiates Phase 3 Trial Of Ataluren
(US) Luminex Receives FDA Clearance For New Cystic Fibrosis Test
(US) Eurand Granted FDA Approval For ZENPEPTM
(US) Liposomal Tobramycin Receives Second Orphan Drug Designation
(UK) Unseen Long-Term Benefits From Cystic Fibrosis Treatments
(US) Can the Common Cold Virus Help Cure Cystic Fibrosis?
(EU) New Test Detects Genetic Abnormalities In Embryos
(EU) Two New Cystic Fibrosis Tests Launched In Europe
(AU) Phase 3 Bronchitol Trial Results Presented at European Conference
(US) Initiation of a Phase 3 registration program for VX-770
(US) Tobramycin Inhalation Powder (TIP) Improved Lung Function In CF
(US) Sodium Channel Blocker Shows Promise For CF
(US) FDA has Approved CREONŽ Delayed-Release Capsules
(UK) Superbug Complicates Treatment Of Infections In Cystic Fibrosis
(US) Orphan Drug Designation For Treatment Against CF Lung Infections
(US) Pharmaxis Announces Positive Results Of Phase 3 CF Trial
(US) Advances in CF Genetic Testing
(US) Sugar On Bacteria Surface Enables The Creation of Biofilms
(US) Two-Pronged Model Could Help Foil Tough Infections
(US) Vertex Initiates Phase 2 Development For CFTR Corrector VX-809
(US) Immune Cells Play Surprising Role In Cystic Fibrosis Lung Damage
(EU) European CHMP Adopts Negative Opinion On Aztreonam Lysine
(US) Strategy Discovered For Fighting Persistent Pseudomonas Infections
(UK) Treatment Of Infections In CF Complicated By B.cepacia
(US) Benign Virus Ideal Carrier in Gene Therapy
(US) Cystic Fibrosis Gene Cure Closer
(US) Nanoemulsion Kills Highly Resistant Bacteria In CF Patients
(US) Innovatively Formulated Pancreatic Enzyme Product
(FR) Test shows correction of Delta F508 CFTR channel with miglustat
(UK) CF Patients' Self-Assessment Can Predict Prognosis
(AU) Early Detection and Treatment of CF Critical
(US) Scientists Spot Key to Cystic Fibrosis Infections
(CA) Stem cells offer new hope to CF patients
(UK) Viral DNA Could Hold Key To Novel CF Treatments
(US) Vertex VX-770 Trial Continues Success in Phase 2
(CA) Research Finds Streptococcus Bug in CF Lungs
(CA) BC Announces NB Screening for CF
(US) Muscular dystropy drug also fights CF
(US) Allabama Introduces New Born Screening for CF
(GB) CF in Mice
(US) KaloBios Initiates Phase 1/2 Trial Of KB001 For Treatment Of Pseudomonas
(US) Lung Transplants Not Dangerous For Children With CF